← DEA Federal Register actions

Schedules of Controlled Substances: Removal of Fenfluramine From Control

hearing · Proposed Rule · Notice of proposed rulemaking. · Published 2022-07-19 · 87 FR 42979

Document

Document number
2022-15335
Federal Register citation
87 FR 42979
Type
Proposed Rule
Action
Notice of proposed rulemaking.
Category
hearing
Publication date
2022-07-19

Abstract

The Drug Enforcement Administration proposes to remove fenfluramine (chemical name: N-ethyl-[alpha]-methyl-3- (trifluoromethyl)phenethylamine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts is possible, from the schedules of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. Fenfluramine is currently a schedule IV controlled substance. This action would remove the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule IV controlled substances, on persons who handle (manufacture, distribute, reverse distribute, import, export, dispense, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle fenfluramine.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown